IP Library Granted Patent US 7,202,066
Granted Patent B2
US 7,202,066 · App. 10/059,627 · Granted Apr 10, 2007

Combination of a growth factor and a protease enzyme

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,066
App. No.
10/059,627
Granted
Apr 10, 2007
Kind
B2
Abstract

A composition combining an extracellular matrix-degrading protease and a growth factor related to epithelial cell functions together without inactivation or degradation of the growth factor by the protease. Preferably, the protease is plasmin/plasminogen or a related one, and the growth factor is KGF or a related one. The combination associates two independent, but synergistic functions essential to the re-epithelialization process or healing process, i.e, stimulating epithelial cell proliferation/differentiation and facilitating its migration by clearing the extracellular matrix components. The combination may be constructed in various ways and can be used to treat wounds or any other disease conditions involving cells of epithelial origin or any other cell types that the growth factor may affect.

Claims (6)

1. A composition comprising:

a mixture formed by mixing keratinocyte growth factor (KGF) and a protease enzyme selected from the group consisting of plasmin and plasminogen, wherein the mixture comprises at least a biologically active fragment of KGF.

2. The composition of claim 1 , wherein the fibroblast growth factor protein has a concentration of from 0.00001% [w/v] to 0.1% [w/v], and the extracellular matrix-degrading protease enzyme has a concentration of from 0.0001 [w/v] to 1% [w/v].

3. The composition of claim 1 further comprising a carrier.

4. The composition of claim 3 , wherein the carrier comprises water, a buffer, a saline solution, a thickener, an emulsion, or an ointment.

5. The composition of claim 3 , wherein the composition and the carrier are lyophilized.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2010
From: DELSITE, INC.
To: NANOTHERAPEUTICS, INC.
Reel/Frame 023796/0607 →